Site-specific methylated reporter constructs for functional analysis of DNA methylation

Epigenetics

Volumn 8, Issue 11, 2013, Pages 1176-1187

  Han, Weiguo ^a   Shi, Miao ^a   Spivack, Simon D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

DNA methylation; Epigenetics; Functional analysis; Site specific DNA methylation; Transcription factor

Indexed keywords

CYTOSINE; DEATH ASSOCIATED PROTEIN KINASE; DNA BINDING PROTEIN; GENOMIC DNA; HISTONE H1; LUCIFERASE; OCTAMER TRANSCRIPTION FACTOR 1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR SP1;

ARTICLE; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; DNA TRANSFECTION; FUNCTIONAL ASSESSMENT; GEL MOBILITY SHIFT ASSAY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NORMAL HUMAN; PROMOTER REGION; PROTEIN DNA BINDING; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION SITE;

DNA METHYLATION; EPIGENETICS; FUNCTIONAL ANALYSIS; SITE-SPECIFIC DNA METHYLATION; TRANSCRIPTION FACTOR;

CPG ISLANDS; DEATH-ASSOCIATED PROTEIN KINASES; DNA METHYLATION; DNA PRIMERS; DNA-BINDING PROTEINS; GENES, REPORTER; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TRANSCRIPTION INITIATION SITE; TUMOR SUPPRESSOR PROTEINS;

EID: 84887493011     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.26195     Document Type: Article

References (78)

1. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007; 447:425-432; PMID:17522676; http://dx.doi.org/10.1038/nature05918
2. Feinberg AP. Phenotypic plasticity and the epi-genetics of human disease. Nature 2007; 447:433-440; PMID:1752267 7; http://dx.doi.org/10.1038/nature05919
3. Berman BP, Weisenberger DJ, Aman JF, Hinoue T, Ramjan Z, Liu Y, Noushmehr H, Lange CP, van Dijk CM, Tollenaar RA, et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet 2012; 44:40-46; PMID:22120008; http://dx.doi.org/10.1038/ng.969
4. Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong CT, Low HM, Kin Sung K W, Rigoutsos I, Loring J, et al. Dynamic changes in the human methylome during differentiation. Genome Res 2010; 20:320-331; PMID:20133333; http://dx.doi.org/10.1101/gr.101907.109
5. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462:315-322; PMID:19829295; http://dx.doi.org/10.1038/nature08514
6. Molaro A, Hodges E, Fang F, Song Q, McCombie WR, Hannon GJ, Smith AD. Sperm methylation profiles reveal features of epigenetic inheritance and evolution in primates. Cell 2011; 146:1029-1041; PM I D: 219253 2 3; http://dx.doi.org/10.1016/j.cell.2011.08.016
7. Hodges E, Molaro A, Dos Santos CO, Thekkat P, Song Q, Uren PJ, Park J, Butler J, Rafii S, McCombie WR, et al. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol Cell 2011; 44:17-28; PMID:21924933; http://dx.doi.org/10.1016/j.molcel.2011.08.026
8. Li Y, Zhu J, Tian G, Li N, Li Q, Ye M, Zheng H, Yu J, Wu H, Sun J, et al. The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol 2010; 8:e1000533; PMID:21085693; http://dx.doi.org/10.1371/journal.pbio.1000533
9. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011; 471:68-73; PMID:21289626; http://dx.doi.org/10.1038/nature09798
10. Curradi M, Izzo A, Badaracco G, Landsberger N. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol Cell Biol 2002; 22:3157-3173; PMID:11940673; http://dx.doi.org/10.1128/MCB.22.9.3157-3173.2002
11. Kawasaki H, Taira K. Induction of DNA meth-ylation and gene silencing by short interfering RNAs in human cells. Nature 2004; 431:211-217; PMID:15311210; http://dx.doi.org/10.1038/nature02889
12. Schoft VK, Chumak N, Mosiolek M, Slusarz L, Komnenovic V, Brownfield L, Twell D, Kakutani T, Tamaru H. Induction of RNA-directed DNA methylation upon decondensation of constitutive heterochromatin. EMBO Rep 2009; 10:1015-1021; PMID:19680290; http://dx.doi.org/10.1038/embor.2009.152
13. Morris K V, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004; 305:1289-1292; PM I D:1529 7624; http://dx.doi.org/10.1126/science.1101372
14. Castanotto D, Tommasi S, Li M, Li H, Yanow S, Pfeifer GP, Rossi JJ. Short hairpin RNA-directed cytosine (CpG) methylation of the RASSF1A gene promoter in HeLa cells. Mol Ther 2005; 12:179-183; P M I D: 159 6 3 9 3 4; http://dx.doi.org/10.1016/j.ymthe.2005.03.003
15. Suzuki K, Shijuuku T, Fukamachi T, Zaunders J, Guillemin G, Cooper D, Kelleher A. Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region. J RNAi Gene Silencing 2005; 1:66-78; PMID:19771207
16. Meister GE, Chandrasegaran S, Ostermeier M. Heterodimeric DNA methyltransferases as a platform for creating designer zinc finger methyltransfer-ases for targeted DNA methylation in cells. Nucleic Acids Res 2010; 38:1749-1759; PMID:20007601; http://dx.doi.org/10.1093/nar/gkp1126
17. Li F, Papworth M, Minczuk M, Rohde C, Zhang Y, Ragozin S, Jeltsch A. Chimeric DNA meth-yltransferases target DNA methylation to specific DNA sequences and repress expression of target genes. Nucleic Acids Res 2007; 35:100-112; P M I D: 171510 7 5; http://dx.doi.org/10.1093/nar/gkl1035
18. Smith AE, Ford KG. Specific targeting of cytosine methylation to DNA sequences in vivo. Nucleic Acids Res 2007; 35:740-754; PMID:17182629; http://dx.doi.org/10.1093/nar/gkl1053
19. Smith AE, Hurd PJ, Bannister AJ, Kouzarides T, Ford KG. Heritable gene repression through the action of a directed DNA methyltransferase at a chromosomal locus. J Biol Chem 2008; 283:9878-9885; PMID:18272522; http://dx.doi.org/10.1074/jbc.M710393200
20. Hsiao SH, Lee KD, Hsu CC, Tseng MJ, Jin VX, Sun WS, Hung YC, Yeh K T, Yan PS, Lai YY, et al. DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determination. Biochem Biophys Res Commun 2010; 400:305-312; PMID:20727853; http://dx.doi.org/10.1016/j.bbrc.2010.08.048
21. Hsu CC, Li HP, Hung YH, Leu YW, Wu WH, Wang FS, Lee KD, Chang PJ, Wu CS, Lu YJ, et al. Targeted methylation of CMV and E1A viral promoters. Biochem Biophys Res Commun 2010; 402:228-234; PMID:20933502; http://dx.doi.org/10.1016/j.bbrc.2010.09.131
22. Teng IW, Hou PC, Lee KD, Chu PY, Yeh KT, Jin VX, Tseng MJ, Tsai SJ, Chang YS, Wu CS, et al. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res 2 011; 71: 4 653-663; P M I D: 21518 7 7 9; http://dx.doi.org/10.1158/0008-5472.CAN-10-3418
23. Klug M, Rehli M. Functional analysis of promoter CpG methylation using a CpG-free lucifer-ase reporter vector. Epigenetics 2006; 1:127-130; PMID:17965610; http://dx.doi.org/10.4161/epi.1.3.3327
24. Arakawa T, Ohta T, Abiko Y, Okayama M, Mizoguchi I, Takuma T. A polymerase chain reaction-based method for constructing a linear vector with site-specific DNA methylation. Anal Biochem 2011; 416: 211-217; PMID:21669180; http://dx.doi.org/10.1016/j.ab.2011.05.017
25. Han W, Cauchi S, Herman JG, Spivack SD. DNA methylation mapping by tag-modified bisulfite genomic sequencing. Anal Biochem 2006; 355:50-61; PMID:16797472; http://dx.doi.org/10.1016/j.ab.2006.05.010
26. Yamada N, Nishida Y, Tsutsumida H, Hamada T, Goto M, Higashi M, Nomoto M, Yonezawa S. MUC1 expression is regulated by DNA meth-ylation and histone H3 lysine 9 modification in cancer cells. Cancer Res 2008; 68:2708-2716; PMID:18413738; http://dx.doi.org/10.1158/0008-5472.CAN-07-6844
27. Taylor KH, Kramer RS, Davis JW, Guo J, Duff DJ, Xu D, Caldwell C W, Shi H. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res 2007; 67:8511-8518; PMID:17875690; http://dx.doi.org/10.1158/0008-5472.CAN-07-1016
28. Krishnakumar R, Gamble MJ, Frizzell KM, Berrocal JG, Kininis M, Kraus WL. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 2008; 319:819-821; PMID:18258916; http://dx.doi.org/10.1126/science.1149250
29. Izzo A, Kamieniarz K, Schneider R. The histone H1 family: specific members, specific functions? Biol Chem 2008; 389:333-343; PMID:18208346; http://dx.doi.org/10.1515/BC.2008.037
30. Happel N, Doenecke D. Histone H1 and its iso-forms: contribution to chromatin structure and function. Gene 2009; 431:1-12; PMID:19 059319; http://dx.doi.org/10.1016/j.gene.2008.11.003
31. Honoré B, Rasmussen HH, Vorum H, Dejgaard K, Liu X, Gromov P, Madsen P, Gesser B, Tommerup N, Celis JE. Heterogeneous nuclear ribonucleoproteins H, H', and F are members of a ubiquitously expressed subfamily of related but distinct proteins encoded by genes mapping to different chromosomes. J Biol Chem 1995; 270:28780-28789; PMID:7499401; http://dx.doi.org/10.1074/jbc.270.48.28780
32. Masuda A, Shen XM, Ito M, Matsuura T, Engel AG, Ohno K. Hnrnp H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Hum Mol Genet 2008; 17:4022-4035; PMID:18806275; http://dx.doi.org/10.1093/hmg/ddn305
33. Wu Q, Gou Y, Wang Q, Jin H, Cui L, Zhang Y, He L, Wang J, Nie Y, Shi Y, et al. Downregulation of RPL6 by siRNA inhibits proliferation and cell cycle progression of human gastric cancer cell lines. PLoS One 2011; 6:e26401; PMID:22043320; http://dx.doi.org/10.1371/journal.pone.0026401
34. Manojlovic Z, Stefanovic B. A novel role of R NA heli-case A in regulation of translation of type I collagen mRNAs. RNA 2012; 18:321-334; PMID:22190748; http://dx.doi.org/10.1261/rna.030288.111
35. Lin L, Li Y, Pyo HM, Lu X, Raman SN, Liu Q, Brown EG, Zhou Y. Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle. J Virol 2012; 86:1942-1954; PMID:22171255; http://dx.doi.org/10.1128/JVI.06362-11
36. Kuroda T, Murayama A, Katagiri N, Ohta YM, Fujita E, Masumoto H, Ema M, Takahashi S, Kimura K, Yanagisawa J. RNA content in the nucle-olus alters p53 acetylation via MYBBP1A. EMBO J 2011; 30:1054-1066; PMID:21297583; http://dx.doi.org/10.1038/emboj.2011.23
37. Owen HR, Elser M, Cheung E, Gersbach M, Kraus WL, Hottiger MO. MYBBP1a is a novel repres-sor of NF-kappaB. J Mol Biol 2007; 366:725-736; PM I D:1719 6 614; http://dx.doi.org/10.1016/j.jmb.2006.11.099
38. Sun J, Lee KJ, Davis AJ, Chen DJ. Human Ku70/80 protein blocks exonuclease 1-mediated DNA resection in the presence of human Mre11 or Mre11/ Rad50 protein complex. J Biol Chem 2012; 287:4936-4945; PMID:22179609; http://dx.doi.org/10.1074/jbc.M111.306167
39. Fell VL, Schild-Poulter C. Ku regulates signaling to DNA damage response pathways through the Ku70 von Willebrand A domain. Mol Cell Biol 2012; 32:76-87; PMID:22037767; http://dx.doi.org/10.1128/MCB.05661-11
40. Screaton GR, Cáceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI, Krainer AR. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 1995; 14:4336-4349; PMID:7556075
41. Phadke M, Krynetskaia N, Mishra A, Krynetskiy E. Accelerated cellular senescence phenotype of GAPDH-depleted human lung carcinoma cells. Biochem Biophys Res Commun 2011; 411:409-415; PM I D: 21749859; http://dx.doi.org/10.1016/j.bbrc.2011.06.165
42. Orloff M, Peterson C, He X, Ganapathi S, Heald B, Yang YR, Bebek G, Romigh T, Song JH, Wu W, et al. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma. JAMA 2011; 306:410-419; PMID:21791690; http://dx.doi.org/10.1001/jama.2011.1029
43. Almeida-Vega S, Catlow K, Kenny S, Dimaline R, Varro A. Gastrin activates paracrine networks leading to induction of PAI-2 via MAZ and ASC-1. Am J Physiol Gastrointest Liver Physiol 2009; 296:G414-G423; PMID:19074 642; http://dx.doi.org/10.1152/ajpgi.90340.2008
44. Privette Vinnedge LM, McClaine R, Wagh PK, Wikenheiser-Brokamp KA, Waltz SE, Wells SI. The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer. Oncogene 2011; 30:2741-2752; PMID:21317931; http://dx.doi.org/10.1038/onc.2011.2
45. Kappes F, Waldmann T, Mathew V, Yu J, Zhang L, Khodadoust MS, Chinnaiyan AM, Luger K, Erhardt S, Schneider R, et al. The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity. Genes Dev 2011; 25:673-678; PMID:21460035; http://dx.doi.org/10.1101/gad.2036411
46. Murai J, Huang SY, Das BB, Dexheimer TS, Takeda S, Pommier Y. Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisom-erases I and II and base alkylation in vertebrate cells. J Biol Chem 2012; 287:12848-12857; PMID:22375014; http://dx.doi.org/10.1074/jbc.M111.333963
47. Hubert L Jr., Lin Y, Dion V, Wilson JH. Topoisomerase 1 and single-strand break repair modulate transcription-induced CAG repeat contraction in human cells. Mol Cell Biol 2011; 31:3105-3112; PMID:21628532; http://dx.doi.org/10.1128/MCB.05158-11
48. Bee A, Brewer D, Beesley C, Dodson A, Forootan S, Dickinson T, Gerard P, Lane B, Yao S, Cooper CS, et al. SIRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer. PLoS One 2011; 6:e22672; PMID:21799931; http://dx.doi.org/10.1371/jour-nal.pone.0022672
49. Kobayashi T, Sasaki Y, Oshima Y, Yamamoto H, Mita H, Suzuki H, Toyota M, Tokino T, Itoh F, Imai K, et al. Activation of the ribosomal protein L13 gene in human gastrointestinal cancer. Int J Mol Med 2006; 18:161-70; PMID:16786168
50. Lines MA, Huang L, Schwartzentruber J, Douglas SL, Lynch DC, Beaulieu C, Guion-Almeida ML, Zechi-Ceide RM, Gener B, Gillessen-Kaesbach G, et al.; FORGE Canada Consortium. Haploinsufficiency of a spliceosomal GTPase encoded by EFTUD2 causes mandibulofacial dysostosis with microcephaly. Am J Hum Genet 2012; 90:369-377; PMID:22305528; http://dx.doi.org/10.1016/j.ajhg.2011.12.023
51. McCloskey A, Taniguchi I, Shinmyozu K, Ohno M. hnRNP C tetramer measures RNA length to classify RNA polymerase II transcripts for export. Science 2012; 335:1643-1646; PM ID:22461616; http://dx.doi.org/10.1126/science.1218469
52. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B. Quantitative mass spectrometry in pro-teomics: a critical review. Anal Bioanal Chem 2007; 389:1017-1031; PMID:17668192; http://dx.doi.org/10.1007/s00216-007-1486-6
53. Han W, Wang T, Reilly AA, Keller SM, Spivack SD. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients. Respir Res 2009; 10:86; PMID:19781081; http://dx.doi.org/10.1186/1465-9921-10-86
54. Cohen O, Feinstein E, Kimchi A. DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associ-ated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J 1997; 16:998-1008; PM ID:9118961; http://dx.doi.org/10.1093/emboj/16.5.998
55. Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T, Feinstein E, Kimchi A. DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain. J Cell Biol 1999; 146:141-148; PMID:10402466
56. Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 2000; 92:1511-1516; PMID:10995806; http://dx.doi.org/10.1093/jnci/92.18.1511
57. Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, Mark EJ, Kelsey K T. Promoter meth-ylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Oncogene 2001; 20:1765-1770; PMID:11313923; http://dx.doi.org/10.1038/sj.onc.1204302
58. Toyooka S, Toyooka KO, Miyajima K, Reddy JL, Toyota M, Sathyanarayana UG, Padar A, Tockman MS, Lam S, Shivapurkar N, et al. Epigenetic down-regulation of death-associated protein kinase in lung cancers. Clin Cancer Res 2003; 9:3034-3041; PMID:12912953
59. Schwartz AG, Prysak GM, Bock CH, Cote ML. The molecular epidemiology of lung cancer. Carcinogenesis 2007; 28:507-518; PMID:17183062; http://dx.doi.org/10.1093/carcin/bgl253
60. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006; 66:3338-3344; PMID:16540689; http://dx.doi.org/10.1158/0008-5472.CAN-05-3408
61. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ. Increasing complexity of Ras signaling. Oncogene 1998; 17(11 Reviews):1395-1413; PMID:9779987; http://dx.doi.org/10.1038/sj.onc.1202174
62. Downward J. The ins and outs of signalling. Nature 2001; 411:759-762; PMID:11459043; http://dx.doi.org/10.1038/35081138
63. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25:315-319; PMID:10888881; http://dx.doi.org/10.1038/77083
64. Burbee DG, Forgacs E, Zöchbauer-Müller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001; 93:691-699; PMID:11333291; http://dx.doi.org/10.1093/jnci/93.9.691
65. Li W, Deng J, Jiang P, Zeng X, Hu S, Tang J. Methylation of the RASSF1A and RARβ genes as a candidate biomarker for lung cancer. Exp Ther Med 2012; 3:1067-1071; PMID:22970018
66. de Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, Mounawar M, Richard N, Antoine M, Rouquette I, Favrot MC, et al.; Intergroupe Francophone de Cancérologie Thoracique. An apop-tosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial. Clin Cancer Res 2012; 18:2976-2986; PMID:22434665; http://dx.doi.org/10.1158/1078-0432.CCR-11-2797
67. Zhang Q, Sun L, Yin L, Ming J, Zhang S, Luo W, Qiu X. CCL19/CCR7 upregulates heparanase via specificity protein-1 (Sp1) to promote invasion of cell in lung cancer. Tumour Biol 2013; (Forthcoming) PMID:23649655
68. Zhao FQ. Octamer-binding transcription factors: genomics and functions. [Landmark Ed]. Front Biosci (Landmark Ed) 2013; 18:1051-1071; PM ID:23747866; http://dx.doi.org/10.2741/4162
69. Ghosh R P, Horowitz-Scherer RA, Nikitina T, Shlyakhtenko LS, Woodcock CL. MeCP2 binds cooperatively to its substrate and competes with his-tone H1 for chromatin binding sites. Mol Cell Biol 2010; 30:4656-4670; PMID:20679481; http://dx.doi.org/10.1128/MCB.00379-10
70. Nan X, Campoy FJ, Bird A. MeCP2 is a tran-scriptional repressor with abundant binding sites in genomic chromatin. Cell 1997; 88:471-481; PMID:9038338; http://dx.doi.org/10.1016/S0092-8674(00)81887-5
71. Maclean JA, Bettegowda A, Kim BJ, Lou CH, Yang SM, Bhardwaj A, Shanker S, Hu Z, Fan Y, Eckardt S, et al. The rhox homeobox gene cluster is imprinted and selectively targeted for regulation by histone h1 and DNA methylation. Mol Cell Biol 2011; 31:1275-1287; PMID:21245380; http://dx.doi.org/10.1128/MCB.00734-10
72. Giambra V, Volpi S, Emelyanov AV, Pflugh D, Bothwell AL, Norio P, Fan Y, Ju Z, Skoultchi AI, Hardy RR, et al. Pax5 and linker histone H1 coordinate DNA methylation and histone modifications in the 3′ regulatory region of the immunoglobulin heavy chain locus. Mol Cell Biol 2008; 28:6123-6133; PMID:18644860; http://dx.doi.org/10.1128/MCB.00233-08
73. Fan Y, Nikitina T, Zhao J, Fleury TJ, Bhattacharyya R, Bouhassira EE, Stein A, Woodcock CL, Skoultchi AI. Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation. Cell 2005; 123:1199-1212; PMID:16377562; http://dx.doi.org/10.1016/j.cell.2005.10.028
74. Wellman SE, Sittman DB, Chaires JB. Preferential binding of H1e histone to GC-rich DNA. Biochemistry 1994; 33:384-388; PMID:8286360; http://dx.doi.org/10.1021/bi00167a049
75. Wellman SE, Song Y, Mamoon NM. Sequence preference of mouse H1(0) and H1t. Biochemistry 1999; 38:13112-13118; PMID:10529182; http://dx.doi.org/10.1021/bi9914917
76. Bonnefoy E, Bandu MT, Doly J. Specific binding of high-mobility-group I (HMGI) protein and histone H1 to the upstream AT-rich region of the murine beta interferon promoter: HMGI protein acts as a potential antirepressor of the promoter. Mol Cell Biol 1999; 19:2803-2816; PMID:10082546
77. Käs E, Izaurralde E, Laemmli UK. Specific inhibition of DNA binding to nuclear scaffolds and histone H1 by distamycin. The role of oligo(dA).oligo(dT) tracts. J Mol Biol 1989; 210:587-599; P M I D: 2 614 8 35; http://dx.doi.org/10.1016/0022-2836(89)90134-4
78. Hisaoka M, Ueshima S, Murano K, Nagata K, Okuwaki M. Regulation of nucleolar chromatin by B23/nucleophosmin jointly depends upon its RNA binding activity and transcription factor UBF. Mol Cell Biol 2010; 30:4952-4964; PMID:20713446; http://dx.doi.org/10.1128/MCB.00299-10